BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20576328)

  • 1. Antimony(III) complexes with 2-benzoylpyridine-derived thiosemicarbazones: cytotoxicity against human leukemia cell lines.
    Reis DC; Pinto MC; Souza-Fagundes EM; Wardell SM; Wardell JL; Beraldo H
    Eur J Med Chem; 2010 Sep; 45(9):3904-10. PubMed ID: 20576328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palladium(II) complexes of 2-benzoylpyridine-derived thiosemicarbazones: spectral characterization, structural studies and cytotoxic activity.
    Rebolledo AP; Vieites M; Gambino D; Piro OE; Castellano EE; Zani CL; Souza-Fagundes EM; Teixeira LR; Batista AA; Beraldo H
    J Inorg Biochem; 2005 Mar; 99(3):698-706. PubMed ID: 15708790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural studies and cytotoxic activity of N(4)-phenyl-2-benzoylpyridine thiosemicarbazone Sn(IV) complexes.
    Perez-Rebolledo A; Ayala JD; de Lima GM; Marchini N; Bombieri G; Zani CL; Souza-Fagundes EM; Beraldo H
    Eur J Med Chem; 2005 May; 40(5):467-72. PubMed ID: 15893020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold(I) complexes with thiosemicarbazones: cytotoxicity against human tumor cell lines and inhibition of thioredoxin reductase activity.
    Lessa JA; Guerra JC; de Miranda LF; Romeiro CF; Da Silva JG; Mendes IC; Speziali NL; Souza-Fagundes EM; Beraldo H
    J Inorg Biochem; 2011 Dec; 105(12):1729-39. PubMed ID: 22005449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ruthenium(II) complexes of 2-benzoylpyridine-derived thiosemicarbazones with cytotoxic activity against human tumor cell lines.
    Graminha AE; Rodrigues C; Batista AA; Teixeira LR; Fagundes ES; Beraldo H
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Apr; 69(4):1073-6. PubMed ID: 17706455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation on the pharmacological profile of antimony(III) complexes with hydroxyquinoline derivatives: anti-trypanosomal activity and cytotoxicity against human leukemia cell lines.
    Reis DC; Pinto MC; Souza-Fagundes EM; Rocha LF; Pereira VR; Melo CM; Beraldo H
    Biometals; 2011 Aug; 24(4):595-601. PubMed ID: 21221718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Benzoylpyridine-N(4)-tolyl thiosemicarbazones and their palladium(II) complexes: cytotoxicity against leukemia cells.
    Ferraz KS; Ferandes L; Carrilho D; Pinto MC; Leite Mde F; Souza-Fagundes EM; Speziali NL; Mendes IC; Beraldo H
    Bioorg Med Chem; 2009 Oct; 17(20):7138-44. PubMed ID: 19773176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mn(II), Co(II) and Zn(II) complexes with heterocyclic substituted thiosemicarbazones: synthesis, characterization, X-ray crystal structures and antitumor comparison.
    Li MX; Chen CL; Zhang D; Niu JY; Ji BS
    Eur J Med Chem; 2010 Jul; 45(7):3169-77. PubMed ID: 20434816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation on the pharmacological profile of 2,6-diacetylpyridine bis(benzoylhydrazone) derivatives and their antimony(III) and bismuth(III) complexes.
    Ferraz KS; Silva NF; da Silva JG; de Miranda LF; Romeiro CF; Souza-Fagundes EM; Mendes IC; Beraldo H
    Eur J Med Chem; 2012 Jul; 53():98-106. PubMed ID: 22520151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic activity, albumin and DNA binding of new copper(II) complexes with chalcone-derived thiosemicarbazones.
    Da Silva JG; Recio Despaigne AA; Louro SR; Bandeira CC; Souza-Fagundes EM; Beraldo H
    Eur J Med Chem; 2013 Jul; 65():415-26. PubMed ID: 23747809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, structural characterization, and biological studies of new antimony(III) complexes with thiones. The influence of the solvent on the geometry of the complexes.
    Ozturk II; Hadjikakou SK; Hadjiliadis N; Kourkoumelis N; Kubicki M; Baril M; Butler IS; Balzarini J
    Inorg Chem; 2007 Oct; 46(21):8652-61. PubMed ID: 17850141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectroscopic and electrochemical characterization of gold(I) and gold(III) complexes with glyoxaldehyde bis(thiosemicarbazones): cytotoxicity against human tumor cell lines and inhibition of thioredoxin reductase activity.
    Lessa JA; Ferraz KS; Guerra JC; de Miranda LF; Romeiro CF; Souza-Fagundes EM; Barbeira PJ; Beraldo H
    Biometals; 2012 Jun; 25(3):587-98. PubMed ID: 22526562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic and antimicrobial effects of indium(iii) complexes with 2-acetylpyridine-derived thiosemicarbazones.
    Oliveira AA; Perdigão GM; Rodrigues LE; da Silva JG; Souza-Fagundes EM; Takahashi JA; Rocha WR; Beraldo H
    Dalton Trans; 2017 Jan; 46(3):918-932. PubMed ID: 28009892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo antitumor activity of platinum(II) complexes with thiosemicarbazones derived from 2-formyl and 2-acetyl pyridine and containing ring incorporated at N(4)-position: synthesis, spectroscopic study and crystal structure of platinum(II) complexes with thiosemicarbazones, potential anticancer agents.
    Kovala-Demertzi D; Papageorgiou A; Papathanasis L; Alexandratos A; Dalezis P; Miller JR; Demertzis MA
    Eur J Med Chem; 2009 Mar; 44(3):1296-302. PubMed ID: 18848372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity and structure-activity relationships of four alpha-N-heterocyclic thiosemicarbazone derivatives crystal structure of 2-acetylpyrazine thiosemicarbazone.
    Li MX; Chen CL; Ling CS; Zhou J; Ji BS; Wu YJ; Niu JY
    Bioorg Med Chem Lett; 2009 May; 19(10):2704-6. PubMed ID: 19369075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vanadium(V) complexes with salicylaldehyde semicarbazone derivatives bearing in vitro anti-tumor activity toward kidney tumor cells (TK-10): crystal structure of [VVO2(5-bromosalicylaldehyde semicarbazone)].
    Noblía P; Vieites M; Parajón-Costa BS; Baran EJ; Cerecetto H; Draper P; González M; Piro OE; Castellano EE; Azqueta A; López de Ceráin A; Monge-Vega A; Gambino D
    J Inorg Biochem; 2005 Feb; 99(2):443-51. PubMed ID: 15621276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallium(III) complexes of 2-pyridineformamide thiosemicarbazones: cytotoxic activity against malignant glioblastoma.
    Mendes IC; Soares MA; Dos Santos RG; Pinheiro C; Beraldo H
    Eur J Med Chem; 2009 May; 44(5):1870-7. PubMed ID: 19070402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organotin(IV) complexes of 2-pyridineformamide-derived thiosemicarbazones: antimicrobial and cytotoxic effects.
    Mendes IC; Moreira JP; Ardisson JD; Santos RG; da Silva PR; Garcia I; Castiñeiras A; Beraldo H
    Eur J Med Chem; 2008 Jul; 43(7):1454-61. PubMed ID: 17983689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. synthesis, characterization and in vitro antiamoebic activity of 5-nitrothiophene-2-carboxaldehyde thiosemicarbazones and their Palladium (II) and Ruthenium (II) complexes.
    Singh S; Bharti N; Naqvi F; Azam A
    Eur J Med Chem; 2004 May; 39(5):459-65. PubMed ID: 15110972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, structural characterization, and pro-apoptotic activity of 1-indanone thiosemicarbazone platinum(II) and palladium(II) complexes: potential as antileukemic agents.
    Gómez N; Santos D; Vázquez R; Suescun L; Mombrú A; Vermeulen M; Finkielsztein L; Shayo C; Moglioni A; Gambino D; Davio C
    ChemMedChem; 2011 Aug; 6(8):1485-94. PubMed ID: 21608131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.